Brief: Gensight Biologics Announces The Results Of Its Extraordinary General Meeting Of January 28, 2026
28/01/2026 23:25
Jan 28 (Reuters) - Gensight Biologics SA SIGHT.PA: GENSIGHT BIOLOGICS ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING OF JANUARY 28, 2026 Source text: ID:nBw6Fst28a Further company coverage: SIGHT.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08